IGMS

IGM Biosciences
IGMS

Overview Fund Activity
Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

89 hedge funds and large institutions have $316M invested in IGM Biosciences in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 19 closing their positions.

Holders
89
Holders Change
-4
Holders Change %
-4.3%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
31
Reduced
26
Closed
19
Calls
$2M
Puts
$252K
Net Calls
+$1.75M
Net Calls Change
-$5.36M

Top Buyers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$47.3M
2
Millennium Management
2
Millennium Management
New York
$10.6M
3
Marshall Wace
3
Marshall Wace
United Kingdom
$4.56M
4
Victory Capital Management
4
Victory Capital Management
Texas
$1.47M
5
Nuveen Asset Management
5
Nuveen Asset Management
Illinois
$1.58M

Top Sellers

1
CAM
1
Cormorant Asset Management
Massachusetts
$0
2
EC
2
EcoR1 Capital
California
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.21M
4
Goldman Sachs
4
Goldman Sachs
New York
$3.58M
5
WP
5
Woodline Partners
California
$3.61M
Name Market Value Shares Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$60.1M 3,334,355 – –
BBA
2
Baker Bros. Advisors
New York
$56.9M 3,156,102 – –
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$47.3M 2,622,873 +376,832 +17%
AG
4
Artal Group
Luxembourg
$36.1M 2,000,000 – –
Alkeon Capital Management
5
Alkeon Capital Management
New York
$18.6M 1,034,035 – –
BlackRock
6
BlackRock
New York
$13M 723,710 +28,886 +4%
Millennium Management
7
Millennium Management
New York
$10.6M 589,401 +368,089 +166%
UBS AM
8
UBS AM
Illinois
$9.67M 536,409 -24,302 -4%
Vanguard Group
9
Vanguard Group
Pennsylvania
$9.21M 510,933 -319,144 -38%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$4.95M 274,554 -111,158 -29%
Marshall Wace
11
Marshall Wace
United Kingdom
$4.56M 252,735 +194,679 +335%
WP
12
Woodline Partners
California
$3.61M 200,047 -203,354 -50%
Goldman Sachs
13
Goldman Sachs
New York
$3.58M 198,554 -229,533 -54%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.55M 196,710 -17,572 -8%
State Street
15
State Street
Massachusetts
$3.38M 187,261 +15,679 +9%
SB
16
Samsara BioCapital
California
$2.79M 154,664 – –
Morgan Stanley
17
Morgan Stanley
New York
$2.26M 125,142 +28,552 +30%
Northern Trust
18
Northern Trust
Illinois
$1.99M 110,606 +25,934 +31%
Voloridge Investment Management
19
Voloridge Investment Management
Florida
$1.83M 101,637 -60,852 -37%
Nuveen Asset Management
20
Nuveen Asset Management
Illinois
$1.58M 87,689 +61,277 +232%
Victory Capital Management
21
Victory Capital Management
Texas
$1.47M 81,263 +70,899 +684%
Dimensional Fund Advisors
22
Dimensional Fund Advisors
Texas
$1.3M 72,150 +15,951 +28%
HF
23
HRT Financial
New York
$1.27M 70,661 +13,075 +23%
Charles Schwab
24
Charles Schwab
California
$1.18M 65,285 -37,338 -36%
BC
25
Bruce & Co
Illinois
$991K 55,000 – –
1
2 3 4 5